What Klonal Laboratories does

Klonal Laboratories (legal name Laboratorios KLONAL) is a privately held Argentine pharmaceutical manufacturer founded in 1975 and headquartered in Buenos Aires, with 101-250 employees. The company develops, manufactures, and distributes generic and branded medications spanning injectables, oral solids, syrups, and topical drops. Its portfolio exceeds 100 products across a broad set of therapeutic categories including anti-infectives (antibiotics such as Amikacina, Meropenem/KLOPENEM, Piperacilina+Tazobactam, Amoxicilina), cardiovascular drugs (Amlodipina/AMLOTENS, Atorvastatin/LIPOVASTATIN, Digoxina/DIGOCARD-G, Espironolactona/ESPIMAX), corticosteroids (BETASONE-G, NEXADRON), ophthalmological solutions (LUBRICTIN, KLONAPROST, CIRFLOX-OFTAL), analgesics, dermatologicals, and pediatric formulations. Manufacturing and R&D are anchored in company-owned industrial plants in Quilmes (Buenos Aires Province) and Córdoba, with a commercial office in the City of Buenos Aires.

The business is organized around three distribution channels that also define its customer segments: Línea Instituciones (hospital and institutional supply of injectable antibiotics, corticosteroids, and specialized medications sold under archived-prescription requirements), Línea Farmacias (retail pharmacy prescription line covering cardiovascular, anti-infective, and specialty formulations), and Venta Libre (over-the-counter products for direct consumer purchase). Revenue is generated through manufacturing and sale of pharmaceutical products across these lines; no pricing is publicly disclosed. Go-to-market relies on event-driven engagement — participation in pharmaceutical industry congresses (e.g., XXV Congreso Argentino de Farmacia Hospitalaria, October 2025; CAO ophthalmology congress) and trade exhibitions — alongside a product catalog website with active-ingredient search and downloadable vademecums.

Operations are certified by the Argentine Ministry of Health (ANMAT), and the company is pursuing international expansion, evidenced by participation in an Argentine commercial mission to Casablanca, Morocco (October 2025). It has also begun digitizing internal processes, implementing the Moondesk platform in September 2025 for labeling traceability and cross-functional quality management. The company appears to be independently owned with no disclosed external institutional investment, parent company, or funding rounds.

Name

Klonal Laboratories

Legal name

Laboratorios KLONAL

Website

https://klonal.com.ar

Company type

Private

Founded year

1975

Operating status

Operating

Headcount range

101–250 employees

Short description

Klonal Laboratories is an Argentine pharmaceutical manufacturer producing generic and branded injectables, oral solids, syrups, and drops across anti-infective, cardiovascular, and ophthalmic categories, serving hospitals, community pharmacies, and consumers through institutional, pharmacy, and over-the-counter channels.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industry

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Generic pharmaceuticals
• Injectable antibiotics
• Cardiovascular medications
• Ophthalmic solutions
• Hospital pharmacy supply

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Manufacturing and selling generic and branded pharmaceutical products across three lines: OTC (Venta Libre), pharmacy prescription (Línea Farmacias), and hospital/institution (Línea Instituciones). Products include antibiotics, anti-inflammatory, cardiovascular, ophthalmic, pediatric, and dermatological medications.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Klonal Laboratories manufactures and markets an extensive portfolio of generic and branded pharmaceutical products including injectable antibiotics, oral solids, syrups, drops, ophthalmic solutions, and topical formulations across anti-infective, cardiovascular, respiratory, musculoskeletal, dermatological, ophthalmological, pediatric, and central nervous system therapeutic categories. The company operates three distribution channels — Línea Instituciones (hospital/institution), Línea Farmacias (retail pharmacy prescription), and Venta Libre (OTC) — serving hospitals, pharmacies, and consumers in Argentina with manufacturing facilities in Quilmes and Córdoba.

Product overview

Klonal Laboratories is an Argentine pharmaceutical company that manufactures and distributes generic and specialty medications across multiple therapeutic categories. The company operates three product lines: Venta Libre (over-the-counter), Línea Farmacias (pharmacy prescription), and Línea Instituciones (hospital/institutional). Product portfolio includes antibiotics (AMOX-G, KLONAM/KLOPENEM carbapenems, DECILINA, PIPERAC COMPUESTO), cardiovascular medications (AMLOTENS amlodipine, LIPOVASTATIN atorvastatin, DIGOCARD-G digoxin, ESPIMAX spironolactone, KLORTIAZIDA), ophthalmological products (LUBRICTIN lubricants, CIRFLOX-OFTAL, KLONAPROST, KLONATROPINA, NEXADRON ophthalmic solutions), corticosteroids (BETASONE-G line, NEXADRON), analgesics (DIPIRONA, IBUPROFENO), and newer launches including Sugammadex Klonal for anesthesia and Bupivacaína Hiperbárica. The company has three manufacturing facilities in Buenos Aires, Quilmes, and Córdoba, Argentina.

Differentiator

Problem solved

Functional benefit

Products and services

• KLONALMOX Suspensión Pediátrica Pediatric amoxicillin + clavulanic acid oral suspension (250mg/62.5mg) for treating bacterial infections in children; prescribed and dispensed through Línea Farmacias.
• AMOX-G Comprimidos Amoxicillin oral tablets, broad-spectrum antibiotic for Gram-positive and Gram-negative bacterial infections, distributed through Línea Farmacias.
• KLOPENEM Inyectable Intravenoso Meropenem 500mg/1g intravenous injectable carbapenem-class broad-spectrum antibiotic for hospital use in serious systemic infections; distributed through Línea Instituciones.
• KLONAM Inyectable Imipenem + Cilastatin 500mg injectable for intravenous use, broad-spectrum carbapenem antibiotic for serious infections; sold under prescription archive through Línea Instituciones.
• PIPERAC COMPUESTO Piperacillin + Tazobactam 4g/500mg injectable antibiotic for intramuscular and intravenous use in hospital settings; distributed through Línea Instituciones.
• AMIKACINA KLONAL Inyectable 500mg Amikacin 500mg/2ml injectable aminoglycoside antibiotic for serious Gram-negative and Gram-positive infections; sold to hospitals and institutions.
• DECILINA 1000mg Inyectable Ampicillin 1g injectable for intramuscular and intravenous administration, beta-lactam antibiotic; sold under prescription archive for hospital use.
• KLONAPROST Solución Oftálmica Latanoprost ophthalmic solution, prostaglandin analog for reducing intraocular pressure in glaucoma patients; dispensed through Línea Farmacias.
• CIRFLOX-OFTAL Solución Oftálmica Estéril Ciprofloxacin 3.5mg + Dexamethasone 1mg sterile ophthalmic suspension for eye infections requiring antibacterial and anti-inflammatory action.
• AMLOTENS 5mg/10mg Comprimidos Amlodipine 5mg and 10mg oral tablets, calcium channel blocker for hypertension and myocardial ischemia/angina treatment; dispensed through Línea Farmacias.
• LIPOVASTATIN KLONAL 10mg/20mg Comprimidos Recubiertos Atorvastatin 10mg/20mg coated tablets, HMG-CoA reductase inhibitor for hypercholesterolemia and lipid reduction; dispensed through Línea Farmacias.
• BETASONE-G RETARD Inyectable Betamethasone Acetate 3mg + Betamethasone Phosphate 3.9mg extended-release injectable corticosteroid for systemic anti-inflammatory and immunosuppressive therapy.
• Sugammadex Klonal Sugammadex (as Sugammadex Sodium) 200mg/2ml solution for intravenous injection, selective relaxant binding agent for reversal of neuromuscular blockade in anesthesia; sold under prescription through Línea Instituciones.
• Bupivacaína Hiperbárica Klonal Hyperbaric Bupivacaine Hydrochloride injectable for regional anesthesia in spinal anesthesia procedures; marketed to hospital pharmacies and anesthesiologists through Línea Instituciones.
• KLOPOXONA Povidone-Iodine 10% topical solution (30ml bottle) for external antiseptic use; available as a Klonal-manufactured antiseptic product.

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• MoondeskcoreTechnology or Integration · 18 September 2025Klonal Laboratories implemented the Moondesk digital platform to improve labeling digitization and traceability processes. This platform integrates teams from Quality Control, Quality Assurance, Supply, Design, Systems, Technical Direction, and Regulatory Affairs to work together on common objectives. This represents a significant step in the company's digital transformation and continuous improvement initiatives.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Teva Pharmaceutical Industries: Global leader in generics with operations across Latin America, offering broad therapeutic categories through hospital and retail channels. Comparable as a much-larger incumbent competing in the same commoditized generic categories (antibiotics, cardiovascular, ophthalmic) as Klonal.
• Pfizer (Established Medicines / Upjohn portfolio): Multinational pharmaceutical company with established medicines portfolio including antibiotics, cardiovascular, and sterile injectable products distributed through hospital and retail channels in Argentina. Comparable as a broad incumbent competing with Klonal's institutional and pharmacy offerings.
• Sandoz (Novartis division): Global generics and biosimilars powerhouse (now independent post-spin-off) with broad antibiotics, cardiovascular, and specialty injectable portfolios. Comparable as a broad incumbent competing across Klonal's core product categories in Argentina and globally.

Direct peers

• Laboratorios Bagó: One of Argentina's largest pharmaceutical companies, manufacturing generics and branded medications across multiple therapeutic categories including antibiotics, cardiovascular, and specialties, sold to hospitals, pharmacies, and export markets—directly comparable to Klonal's three-channel, multi-therapeutic model.
• Laboratorios Gador: Argentine pharmaceutical manufacturer producing generics and specialty drugs distributed through hospital, pharmacy, and OTC channels across South America. Overlapping product categories (antibiotics, cardiovascular, dermatological) make it a directly comparable Argentine peer.
• Laboratorios Roemmers: One of Argentina's largest pharma companies operating a broad therapeutic portfolio (anti-infectives, cardiovascular, specialty) with manufacturing and dedicated hospital/pharmacy/OTC channels—comparable to Klonal across product breadth and channel structure, though larger in scale.
• Laboratorios Richmond: Argentine pharma laboratory focused on generics, branded generics, and biosimilars with active institutional and pharmacy distribution. Comparable to Klonal in therapeutic breadth, manufacturing footprint, and Argentine market positioning.
• Genomma Lab Argentina: Latin American OTC and consumer-health pharma with strong presence in Argentina covering analgesics, cold/flu, dermatology. Overlaps directly with Klonal's Venta Libre OTC line and self-medication consumer persona.
• ELEA (Laboratorios ELEA): Argentine pharma manufacturer with diverse portfolio across central nervous system, cardiovascular, women's health, and specialty categories distributed via hospitals and pharmacies. Comparable multi-therapeutic Argentine peer with similar distribution model.

Regional players

• Eurofarma Laboratórios: Brazilian-headquartered pharmaceutical company with strong LATAM presence in generics and branded generics across multiple therapeutic areas. Comparable as a regional Latin American generics competitor, though not directly active in Argentina.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/klonal-laboratorios

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Klonal Laboratories